Chromatin–IgG complexes activate B cells by dual engagement of IgM and Toll-like receptors

No abstract is available for this paper.

• Publication year

  2002

• Venue

  Nature

• Publication date

  2002-04-11

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1038/416603aPMID 11948342
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Cutting Edge: Immune Stimulation by Neisserial Porins Is Toll-Like Receptor 2 and MyD88 Dependent1

  2002cited by this paper
• Evolution of Autoantibody Responses via Somatic Hypermutation Outside of Germinal Centers

  2002cited by this paper
• Toll-like receptors: critical proteins linking innate and acquired immunity

  2001cited by this paper
• CpG Stimulation of Primary Mouse B Cells Is Blocked by Inhibitory Oligodeoxyribonucleotides at a Site Proximal to NF-κB Activation

  2001cited by this paper
• CpG stimulation of primary mouse B cells is blocked by inhibitory oligodeoxyribonucleotides at a site proximal to NF-kappaB activation.

  2001cited by this paper
• Phagocytosis and clearance of apoptotic cells is mediated by MER

  2001cited by this paper
• An Essential Role of the NF-κB/Toll-Like Receptor Pathway in Induction of Inflammatory and Tissue-Repair Gene Expression by Necrotic Cells1

  2001cited by this paper
• TIRAP: an adapter molecule in the Toll signaling pathway

  2001cited by this paper
• A Toll-like receptor recognizes bacterial DNA

  2000cited by this paper
• Immune Complexes Present in the Sera of Autoimmune Mice Activate Rheumatoid Factor B Cells1

  2000cited by this paper
• Cutting Edge: A Role for CD1 in the Pathogenesis of Lupus in NZB/NZW Mice1

  2000cited by this paper
• Immune Cell Activation by Bacterial Cpg-DNA through Myeloid Differentiation Marker 88 and Tumor Necrosis Factor Receptor–Associated Factor (Traf)6

  2000cited by this paper
• Features of systemic lupus erythematosus in Dnase1-deficient mice

  2000cited by this paper
• Unresponsiveness of MyD88-deficient mice to endotoxin.

  1999cited by this paper
• Autoantigen-Specific B Cell Activation in FAS-Deficient Rheumatoid Factor Immunoglobulin Transgenic Mice

  1999cited by this paper
• Serum amyloid P component controls chromatin degradation and prevents antinuclear autoimmunity

  1999cited by this paper
• DNA methylation.

  1999cited by this paper
• Dose-loading with hydroxychloroquine improves the rate of response in early, active rheumatoid arthritis: a randomized, double-blind six-week trial with eighteen-week extension.

  1999cited by this paper
• Homozygous C1q deficiency causes glomerulonephritis associated with multiple apoptotic bodies

  1998cited by this paper
• CpG‐DNA‐specific activation of antigen‐presenting cells requires stress kinase activity and is preceded by non‐specific endocytosis and endosomal maturation

  1998cited by this paper
• CpG motifs in bacterial DNA activate leukocytes through the pH-dependent generation of reactive oxygen species.

  1998cited by this paper
• Targeted disruption of the MyD88 gene results in loss of IL-1- and IL-18-mediated function.

  1998cited by this paper
• Seeking wisdom in innate immunity

  1997cited by this paper
• A human homologue of the Drosophila Toll protein signals activation of adaptive immunity

  1997cited by this paper
• The dorsoventral regulatory gene cassette spätzle/Toll/cactus controls the potent antifungal response in Drosophila adults.

  1996cited by this paper
• A disease-related rheumatoid factor autoantibody is not tolerized in a normal mouse: implications for the origins of autoantibodies in autoimmune disease

  1996cited by this paper
• Disruption of the Cr2 locus results in a reduction in B-1a cells and in an impaired B cell response to T-dependent antigen.

  1996cited by this paper
• Specificities and genetic characteristics of nucleosome-reactive antibodies from autoimmune mice.

  1996cited by this paper
• How MHC class II molecules reach the endocytic pathway.

  1995cited by this paper
• An isotype switched and somatically mutated rheumatoid factor clone isolated from a MRL-lpr/lpr mouse exhibits limited intraclonal affinity maturation.

  1994cited by this paper
• A rheumatoid factor transgenic mouse model of autoantibody regulation.

  1993cited by this paper
• Regulation of nuclear antigen expression on the cell surface of human monocytes.

  1992cited by this paper
• A randomized study of the effect of withdrawing hydroxychloroquine sulfate in systemic lupus erythematosus.

  1991cited by this paper
• The spontaneous apoptotic cell death of normal human lymphocytes in vitro: the release of, and immunoproliferative response to, nucleosomes in vitro.

  1991cited by this paper
• Immunogenic DNA-related factors. Nucleosomes spontaneously released from normal murine lymphoid cells stimulate proliferation and immunoglobulin synthesis of normal mouse lymphocytes.

  1990cited by this paper
• Antinuclear antibodies: diagnostic markers for autoimmune diseases and probes for cell biology.

  1989cited by this paper
• Oligoclonality of rheumatoid factors arising spontaneously in lpr/lpr mice.

  1988cited by this paper
• Synergistic interaction between complement receptor type 2 and membrane IgM on B lymphocytes.

  1988cited by this paper
• The role of clonal selection and somatic mutation in autoimmunity

  1987cited by this paper
• Association of lpr gene with graft-vs.-host disease-like syndrome

  1985cited by this paper
• Lipopolysaccharides can convert heterologous red cells into thymus-independent antigens.

  1972cited by this paper

• Serological Stratification by Anti-Ro52 and Anti-Ro60 Profiles Reveals Distinct Systemic Phenotypes in Primary Sjögren's Disease.

  2026cites this paper
• Plasmablast Storms: Microbial Drivers of Acute and Chronic Autoimmune Flares

  2026cites this paper
• Dihydroartemisinin attenuates pemphigus vulgaris by regulating Dsg3 and the TLR9/NF-κB pathway.

  2026cites this paper
• Tlr9 expression protects against Tlr7-dependent exocrine gland and systemic disease manifestations in primary Sjögren's disease in a sex-biased manner.

  2025cites this paper
• Function and Regulation of Age‐Associated B Cells in Diseases

  2025cites this paper
• From genetic code to global health: the impact of nucleic acid vaccines on disease prevention and treatment.

  2025cites this paper
• Neutrophils‐ and Pyroptosis‐Related Genes IL1B and PYCARD as Diagnostic Biomarkers for Systemic Lupus Erythematosus

  2025cites this paper
• Artemisinins in autoimmune diseases: effects and mechanisms in systemic lupus erythematosus and rheumatoid arthritis

  2025cites this paper
• An essential role for TASL in mouse autoimmune pathogenesis and Toll-like receptor signaling

  2025cites this paper
• Chronic intermittent hypoxia drives M1 macrophage polarization in dorsal root ganglia

  2025cites this paper
• Multiomic analysis reveals a key BCAT1 role in mTOR activation by B cell receptor and TLR9

  2025cites this paper
• Critical roles of chronic BCR signaling in the differentiation of anergic B cells into age-associated B cells in aging and autoimmunity

  2025cites this paper
• New insights into the role of IFN-α/β and TLR7/8/9 in cancer immunotherapy and systemic autoimmunity

  2025cites this paper
• A triad of somatic mutagenesis converges in self-reactive B cells to cause a virus-induced autoimmune disease.

  2025cites this paper
• Targeting age-related cell-free DNA for prevention, early diagnosis and treatment of rheumatoid arthritis.

  2025cites this paper
• PD-1 expression identifies proliferating malignant CLL B cells and is a potential biomarker of response to BTK inhibitor therapy.

  2025cites this paper
• Research progress on the cross-regulation between ferroptosis and immunogenic cell death in tumor micro-environment

  2025cites this paper
• Pam3CSK4 as a Cross-Species Adjuvant for Polysaccharide Vaccines: Efficacy in Humanized Mouse and Non-Human Primate Models

  2025cites this paper
• Innate Immune Receptors as Dynamic Modulators of Extrafollicular Autoimmune B Cell Response

  2025influential citation
• Macrophage-centred crosstalk with infiltrating immune cells in rheumatoid arthritis and its regulation by mesenchymal stem cells

  2025cites this paper
• Acute Sleep Deprivation and the Autoimmune TLR-BANK1 Pathway: Interplay with Gender and Emotional State

  2025cites this paper
• Opportunities and limitations of B cell depletion approaches in SLE

  2025cites this paper
• Autophagy Differentially Influences Toll-like Receptor 9 and B Cell-Receptor-Mediated B Cell Expansion, Expression of Major Histocompatibility Class II Proteins, and Antigenic Peptide Presentation

  2025cites this paper
• Antibody reactivity against EBNA1 and GlialCAM differentiates multiple sclerosis patients from healthy controls

  2025cites this paper
• Toll-like Receptors and Inflammatory Cytokines in the Skin of Acanthamoeba spp. Infected Immunocompetent and Immunosuppressed Mice.

  2025cites this paper
• What's Atypical about Human B cells after Allogeneic Stem Cell Transplantation?

  2025cites this paper
• Immunoregulatory properties of cell free DNA

  2025cites this paper
• The Role of Podocytes in Lupus Pathology

  2024cites this paper
• Failed Downregulation of PI3K Signaling Makes Autoreactive B Cells Receptive to Bystander T Cell Help.

  2024cites this paper
• Targeting TLR Signaling Cascades in Systemic Lupus Erythematosus and Rheumatoid Arthritis: An Update

  2024cites this paper
• The role of immune system in atherosclerosis: Molecular mechanisms, controversies, and future possibilities.

  2024cites this paper
• B cell activation and autoantibody production in autoimmune diseases.

  2024cites this paper
• Serological Antibodies against Kidney, Liver, and Spleen Membrane Antigens as Potential Biomarkers in Patients with Immune Disorders

  2024cites this paper
• Directing risky traffic in B cells with TNIP1

  2024cites this paper
• TLR2 Activation as a Marker of Severe COVID-19 and a Potential Therapeutic Target.

  2024cites this paper
• TRAF3 regulation of proximal TLR signaling in B cells.

  2024cites this paper
• The path ahead for understanding Toll-like receptors-driven systemic autoimmunity.

  2024cites this paper
• Immunity and Coagulation in COVID-19

  2024cites this paper
• Multi-omic Analysis of Human B-cell Activation Reveals a Key Lysosomal BCAT1 Role in mTOR Hyperactivation by B-cell receptor and TLR9

  2024cites this paper
• Human and Murine Toll-like Receptor-Driven Disease in Systemic Lupus Erythematosus

  2024cites this paper
• ADA2 is a lysosomal deoxyadenosine deaminase acting on DNA involved in regulating TLR9-mediated immune sensing of DNA.

  2024cites this paper
• Toll-like receptor 9 (TLR9) genetic variants rs187084 and rs352140 confer protection from Behcet’s disease among Iranians

  2024cites this paper
• Control of adaptive immunity by pattern recognition receptors.

  2024cites this paper
• B cell dysregulation and depletion therapy in primary membranous nephropathy: Prospects and potential challenges.

  2024cites this paper
• Decoding Toll-like receptors: Recent insights and perspectives in innate immunity.

  2024cites this paper
• Toll-like receptors 7 and 9 regulate the proliferation and differentiation of B cells in systemic lupus erythematosus

  2023cites this paper
• Stimulator of interferon genes is required for Toll-Like Receptor-8 induced interferon response

  2023cites this paper
• Mangiferin protects DNase 2 abundance via Nrf2 activation to prevent cytosolic mtDNA accumulation during liver injury.

  2023cites this paper
• Pathogenesis of systemic lupus erythematosus: risks, mechanisms and therapeutic targets

  2023cites this paper
• For whom the B(c)ell tolls: CXCL4 AIDs human autoimmunity

  2023cites this paper
• Heightened TLR7 signaling primes BCR-activated B cells in chronic graft-versus-host disease for effector functions

  2023cites this paper
• An Emerging Role for Anti-DNA Antibodies in Systemic Lupus Erythematosus

  2023cites this paper
• Lupus mice derived mesenchymal stromal cells: Beneficial or detrimental on SLE disease outcome.

  2023cites this paper
• Toll-like receptor-guided therapeutic intervention of human cancers: molecular and immunological perspectives

  2023cites this paper
• Disease in the Pld4thss/thss Model of Murine Lupus Requires TLR9

  2023cites this paper
• Failed down-regulation of PI3K signaling makes autoreactive B cells receptive to bystander T cell help

  2023cites this paper
• Phospholipase D4 as a signature of toll-like receptor 7 or 9 signaling is expressed on blastic T-bet + B cells in systemic lupus erythematosus

  2023cites this paper
• The Role of the Oxidative State and Innate Immunity Mediated by TLR7 and TLR9 in Lupus Nephritis

  2023cites this paper
• A comprehensive review on the dynamic role of toll-like receptors (TLRs) in frontier aquaculture research and as a promising avenue for fish disease management.

  2023cites this paper
• A Comprehensive Literature Review on Managing Systemic Lupus Erythematosus: Addressing Cardiovascular Disease Risk in Females and Its Autoimmune Disease Associations

  2023cites this paper
• B cell–intrinsic TLR7 expression drives severe lupus in TLR9-deficient mice

  2023cites this paper
• From systemic lupus erythematosus to lupus nephritis: The evolving road to targeted therapies.

  2023cites this paper
• Irradiation Attenuates Systemic Lupus Erythematosus-Like Morbidity in NZBWF1 Mice: Focusing on CD180-Negative Cells

  2023cites this paper
• Tocilizumab suppresses NF-kappa B activation via toll-like receptor 9 signaling by reducing cell-free DNA in rheumatoid arthritis.

  2023cites this paper
• Cytoplasmic DNA sensing boosts CD4+ T cell metabolism for inflammatory induction

  2023cites this paper
• Expression Improvement of Recombinant Plasmids of the Interleukin-7 Gene in Chitosan-Derived Nanoparticles and Their Elevation of Mice Immunity

  2023cites this paper
• Kinetics of specific anti-SARS-CoV-2 IgM, IgA, and IgG responses during the first 12 months after SARS-CoV-2 infection: A prospective longitudinal study

  2023cites this paper
• Resolving a paradox between mouse and man: a genetic link between TLR7 and the pathogenesis of human lupus nephritis.

  2023cites this paper
• Application of toll-like receptors (TLRs) and their agonists in cancer vaccines and immunotherapy

  2023cites this paper
• Isolated anti-Ro52 identifies a severe subset of Sjögren’s syndrome patients

  2023cites this paper
• Glucose Requirement of Antigen-Specific Autoreactive B Cells and CD4+ T Cells.

  2023cites this paper
• Dual stimulation by autoantigen and CpG fosters the proliferation of exhausted rheumatoid factor-specific CD21low B cells in hepatitis C virus-cured mixed cryoglobulinemia

  2023cites this paper
• NF-kB and the CLL microenvironment

  2023cites this paper
• Validation of a murine proteome-wide phage display library for the identification of autoantibody specificities

  2023cites this paper
• Validation of a murine proteome-wide phage display library for identification of autoantibody specificities

  2023cites this paper
• CXCL4 synergizes with TLR8 for TBK1-IRF5 activation, epigenomic remodeling and inflammatory response in human monocytes

  2022cites this paper
• From risk to chronicity: evolution of autoreactive B cell and antibody responses in rheumatoid arthritis

  2022cites this paper
• Structural epitope profiling identifies antibodies associated with critical COVID-19 and long COVID

  2022cites this paper
• Genetic obstacles to developing and tolerizing human B cells.

  2022cites this paper
• Fas ligand promotes an inducible TLR-dependent model of Fas ligand promotes an inducible TLR-dependent model of cutaneous lupus-like inflammation cutaneous lupus-like inflammation us know how access this document you.

  2022cites this paper
• Extrafollicular responses are sufficient to drive initiation of autoimmunity and early disease hallmarks of lupus

  2022cites this paper
• Many Achilles’ heels of B and T cell tolerance

  2022cites this paper
• Toll-like receptors: new targets for multiple myeloma treatment?

  2022cites this paper
• B Cells on the Stage of Inflammation in Juvenile Idiopathic Arthritis: Leading or Supporting Actors in Disease Pathogenesis?

  2022cites this paper
• Targeting DAMPs with Nucleic Acid Scavengers to Treat Lupus.

  2022cites this paper
• Germinal center block exacerbates extrafollicular responses and 1 accelerates autoimmune disease progression in a murine lupus 2 model 3 4

  2022cites this paper
• Regulatory strategies limiting endosomal Toll‐like receptor activation in B cells *

  2022cites this paper
• Nucleic Acid Sensing and Systemic Lupus Erythematosus: The Danger of Self

  2022cites this paper
• Role of inhibitory B cell co‐receptors in B cell self‐tolerance to non‐protein antigens *

  2022cites this paper
• Nanoengineered therapy aiming at the etiology of rheumatoid arthritis

  2022cites this paper
• Transforming mutations in the development of pathogenic B cell clones and autoantibodies *

  2022cites this paper
• Chloroquine Suppresses Effector B-Cell Functions and Has Differential Impact on Regulatory B-Cell Subsets

  2022cites this paper
• Autoreactive B cells recruited to lungs by silica exposure contribute to local autoantibody production in autoimmune-prone BXSB and B cell receptor transgenic mice

  2022cites this paper
• Micro RNA 145 targets the insulin receptor substrate-1 and inhibits the growth of colon cancer cells

  2022cites this paper
• Systemic Lupus Erythematosus Pathogenesis: Interferon and Beyond.

  2022cites this paper
• Differential effects of periodontal microbiome on the rheumatoid factor induction during rheumatoid arthritis pathogenesis

  2022cites this paper
• Toll-like receptor-targeted anti-tumor therapies: Advances and challenges

  2022cites this paper
• Structural epitope profiling identifies antibodies associated with critical COVID-19 and long COVID

  2022cites this paper
• The extrafollicular response is sufficient to drive initiation of autoimmunity and early disease hallmarks of lupus

  2022cites this paper
• Cell-Free DNA in the Pathogenesis and Therapy of Non-Infectious Inflammations and Tumors

  2022cites this paper